News

Vaccine Advisory Panel Holds Off on Adult PCV13 Recommendation


 

FROM A MEETING OF THE CENTERS FOR DISEASE CONTROL AND PREVENTION'S ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES

Dr. Bennett stated that she has no disclosures. Dr. Schaffner serves on the data safety monitoring board for Sanofi-Pasteur and Merck, and is an occasional consultant for Novartis, GlaxoSmithKline, and Pfizer.

Pages

Recommended Reading

Hep B for Diabetes Patients Tops Vaccine Recs for 2012
MDedge Internal Medicine
C. difficile Diarrhea Can Be Linked to PPIs, FDA Says
MDedge Internal Medicine
Amoxicillin No Better Than Placebo for Rhinosinusitis
MDedge Internal Medicine
Confronting UTI Antimicrobial Resistance: What’s Up Our Sleeve?
MDedge Internal Medicine
PCV13 Works Best Against Pneumococcal Disease in Adults
MDedge Internal Medicine
Oral Probiotics May Resolve Chronic Vulvovaginal Candidiasis
MDedge Internal Medicine
Her Chief Complaint Is ... And by the Way She’s Also Pregnant
MDedge Internal Medicine
Pertussis Immunization Recommended for Adults 65 and Older
MDedge Internal Medicine
Recognizing Care for Complex Patients
MDedge Internal Medicine
U.S. 2011-2012 Flu Season Gets Late Start
MDedge Internal Medicine